ACS OmegaMicrobiologyPeer-reviewed journal article
Loratadine decreases methicillin-resistant Staphylococcus aureus virulence through global hemolysin regulators vraSR and agr.
Chase Dillon, Isabel Marshall, Maggy Henkel, Halie Balogh, Robin Stempel, E. Renee Monge, Gabriel Z. Valenzano, Meghan S. BlackledgeiD, Heather B. MilleriD
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterial pathogen that relies on expression of a wide range of virulence factors. Hemolysins are a diverse collection of cytolytic toxins that promote virulence by being excreted and lysing host blood cells. We previously reported on novel anti-virulence compounds that modulate hemolysis in vitro, including a brominated carbazole (compound 8) and the active ingredient in Claritin (loratadine). We analyzed expression and activity of MRSA hemolysins in two hospital-acquired strains. Even with the same staphylococcal cassette chromosome mec (SCCmec) type, the strains displayed unique responses to loratadine where both repression and elevation of hemolysis occurred. These compounds are potentially binding and regulating the master regulatory protein, Stk1, which has known ties to hemolysis in S. aureus. We hypothesized that modulation of hemolysis by these putative Stk1 inhibitors would extend to community-acquired strains of MRSA. Furthermore, we wanted to determine if Stk1 was the only hemolysis regulatory protein being engaged by these compounds. To test this, we examined compound 8 and loratadines effects on two different USA300 strains, in addition to transposon mutants for a range of hemolysis regulatory genes. We observed strain-specific regulation of hemolysis by Stk1. Loratadine continued to downregulate both alpha and beta hemolytic activity in USA300 JE2 in both Stk1-dependent and independent pathways. Additionally, we report that this anti-virulence compound effectively disrupts hemolysis by modulating both agr and vraSR global regulators, contributing to widespread cytotoxin repression. Both alpha hemolysin (hla) and RNAIII/delta hemolysin (hld) mRNA reductions occurred in vitro and in a human cell line model of MRSA infection. Together, these results expand our knowledge of loratadines mode of action as a virulence modulator.
- organism: bacteria (other)
- assay: DNA methylation
- research focus: host-pathogen & immune response
- research focus: differential expression
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 20%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Novel Anti-virulence Compounds Disrupt Exotoxin Expression in MRSA
Halie Balogh, Amaiya K. Anthony, … Heather B. Miller·Microbiology SpectrumPeer-reviewed·Oct 21, 2024
- β-lactam Antibiotics Stimulate the Pathogenicity of Methicillin-resistant Staphylococcus aureus Via SarA-controlled Tandem Lipoprotein Expression
- Discovery of genes encoding a Streptolysin S-like toxin biosynthetic cluster in a select highly pathogenic methicillin resistant Staphylococcus aureus JKD6159 strain
T. Kane, K. E. Carothers, … S. W. Lee·bioRxiv·Aug 31, 2019
- Significant Variability exists in the Toxicity of Global Methicillin-resistant Staphylococcus aureus Lineages.
M. Laabei, S. Peacock, … R. C. Massey·bioRxiv·Jul 16, 2021
- Structure-Based Discovery of a Novel Small-Molecule Inhibitor of Methicillin-Resistant S. aureus
M. Lu, J. Liu, L. Kozhaya·bioRxiv·Oct 1, 2019
- The histidine kinase VraS orchestrates the cell-wall stress response in Staphylococcus aureus via its direct interaction with glycopeptides and β-lactams
Melisa B. Antinori, David Sychantha, … Leticia Irene Llarrull·bioRxiv·Jan 23, 2025